Showing results (191-200 of 686) with videos related to

Sort By:
Pageof 69
Cancer Research|March 1, 1981
Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid mediumH Nederbragt, M P Uitendaal, L van der Grint, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Pharmacokinetics and toxicity of mitomycin C in rodents, given alone, in combination, or after induction of microsomal drug metabolismS Kerpel-Fronius, J Verwey, M Stuurman, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1985
The absence of influence of acetylsalicylic acid (ASA) on the transient decrease in platelet counts observed after infusion of bleomycin and vinblastineJ Verweij, D M Kester, W P Breed, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
The cold pressor test during radionuclide ventriculography: a feasibility study in cancer patientsJ Verwey, A Van Lingen, J J Teule, et al.
Cancer Treatment Reports|June 1, 1986
Clinical and pharmacokinetic studies of prolonged administration of high-dose uridine intended for rescue from 5-FU toxicityC J van Groeningen, A Leyva, I Kraal, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate. Estimation of the effect of protecting agents on the plasma and peritoneal AUCs of CDDPO R Leeuwenkamp, W J van der Vijgh, J P Neijt, et al.
Biochemical Pharmacology|April 12, 1996
Regulation of phosphorylation of deoxycytidine and 2',2'-difluorodeoxycytidine (gemcitabine); effects of cytidine 5'-triphosphate and uridine 5'-triphosphate in relation to chemosensitivity for 2',2'-difluorodeoxycytidineV W van Haperen, G Veerman, J B Vermorken, et al.
International Journal of Cancer|April 22, 1992
Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenograftsC F Molthoff, H M Pinedo, H M Schlüper, et al.
Journal of the National Cancer Institute|January 18, 1989
Reversal of 5-fluorouracil-induced myelosuppression by prolonged administration of high-dose uridineC J van Groeningen, G J Peters, A Leyva, et al.
Biochemical Pharmacology|November 6, 1991
The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatinM Treskes, U Holwerda, I Klein, et al.
Pageof 69